CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 41 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $25,000 | +8.7% | 4,500 | 0.0% | 0.00% | – |
| Q3 2016 | $23,000 | +15.0% | 4,500 | 0.0% | 0.00% | – |
| Q2 2016 | $20,000 | 0.0% | 4,500 | 0.0% | 0.00% | – |
| Q1 2016 | $20,000 | -16.7% | 4,500 | 0.0% | 0.00% | – |
| Q4 2015 | $24,000 | -7.7% | 4,500 | 0.0% | 0.00% | – |
| Q3 2015 | $26,000 | -39.5% | 4,500 | -24.5% | 0.00% | – |
| Q2 2015 | $43,000 | +4.9% | 5,963 | -2.6% | 0.00% | – |
| Q1 2015 | $41,000 | +10.8% | 6,121 | 0.0% | 0.00% | – |
| Q4 2014 | $37,000 | +23.3% | 6,121 | 0.0% | 0.00% | – |
| Q3 2014 | $30,000 | +7.1% | 6,121 | 0.0% | 0.00% | – |
| Q2 2014 | $28,000 | 0.0% | 6,121 | 0.0% | 0.00% | – |
| Q1 2014 | $28,000 | +33.3% | 6,121 | +45.6% | 0.00% | – |
| Q4 2013 | $21,000 | -91.4% | 4,205 | -92.2% | 0.00% | – |
| Q3 2013 | $243,000 | -51.1% | 53,691 | -44.8% | 0.00% | -100.0% |
| Q2 2013 | $497,000 | – | 97,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Financial Planning, Inc. | 22,031 | $46,000 | 0.03% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 189,048 | $392,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $595,000 | 0.01% |
| Renaissance Technologies | 622,228 | $1,291,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $390,000 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $6,000 | 0.00% |
| BlackRock Inc. | 140,248 | $292,000 | 0.00% |
| Citadel Advisors | 32,300 | $67,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 28,900 | $60,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 34,592 | $72,000 | 0.00% |